drugset / Trial / NCT01379677

Rubidium-82 PET and Tc-99m-MIBI SPET: A Head to Head Comparison

NCT01379677

Phase 3 Completed 135 enrolled Advanced Accelerator Applications
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The main purpose of this study is to compare myocardial perfusion imaging using Rubidium-82 PET with Tc-99m-MIBI SPET, in the evaluation of significant Coronary Artery Disease (CAD).

Timeline

Start
2011-02
Primary completion
2013-11
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Rubidium-82 Diagnostic / imaging agent 2200 mbq Intravenous
Subject TECHNETIUM SESTAMIBI Diagnostic / imaging agent 1000 mbq Intravenous